Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning
Natalie R.S. Goldberg, Tom Hampton, Scott McCue, et al.
Journal of Neuroscience Research (2011) Vol. 89, Iss. 10, pp. 1698-1706
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors
Kelly M. Hinkle, Mei Yue, Bahareh Behrouz, et al.
Molecular Neurodegeneration (2012) Vol. 7, Iss. 1
Open Access | Times Cited: 182
Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease
Kelly E. Glajch, Sheila M. Fleming, D. James Surmeier, et al.
Behavioural Brain Research (2011) Vol. 230, Iss. 2, pp. 309-316
Open Access | Times Cited: 146
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
Michał Węgrzynowicz, Dana Bar-On, Laura Calò, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 4, pp. 575-595
Open Access | Times Cited: 101
Solvents and Parkinson disease: A systematic review of toxicological and epidemiological evidence
Edward A. Lock, Jing Zhang, Harvey Checkoway
Toxicology and Applied Pharmacology (2012) Vol. 266, Iss. 3, pp. 345-355
Open Access | Times Cited: 71
Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease
Xiaohong Wang, Gang Lü, Xiang Hu, et al.
BMC Neuroscience (2012) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice
Supriti Samantaray, Varduhi H. Knaryan, Donald C. Shields, et al.
Molecular Neurobiology (2015) Vol. 52, Iss. 2, pp. 1054-1066
Open Access | Times Cited: 55
Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson’s disease
Michelle D. Sconce, Madeline J. Churchill, Rebecca E. Greene, et al.
Neuroscience (2015) Vol. 299, pp. 156-174
Closed Access | Times Cited: 52
Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson’s disease
Michelle D. Sconce, Madeline J. Churchill, Charity G. Moore, et al.
Neuroscience (2015) Vol. 290, pp. 454-471
Closed Access | Times Cited: 51
Roflupram exerts neuroprotection via activation of CREB/PGC‐1α signalling in experimental models of Parkinson's disease
Jiahong Zhong, Wenli Dong, Yunyun Qin, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 10, pp. 2333-2350
Open Access | Times Cited: 47
Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson’s disease
Caroline J. Zeiss, Heather Allore, Amanda P. Beck
PLoS ONE (2017) Vol. 12, Iss. 2, pp. e0171790-e0171790
Open Access | Times Cited: 42
Early life exposure to permethrin: a progressive animal model of Parkinson's disease
Cinzia Nasuti, Gloria Brunori, Piera Eusepi, et al.
Journal of Pharmacological and Toxicological Methods (2016) Vol. 83, pp. 80-86
Closed Access | Times Cited: 40
The Nurr1 Ligand,1,1-bis(3′-Indolyl)-1-(p-Chlorophenyl)Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism
Sean L. Hammond, Katriana A. Popichak, Xi Li, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 3, pp. 636-651
Open Access | Times Cited: 39
Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease
Michelle S. Massaquoi, William A. Liguore, Madeline J. Churchill, et al.
Neuroscience (2020) Vol. 433, pp. 53-71
Closed Access | Times Cited: 38
Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
Natalie R.S. Goldberg, Victoria L. Fields, Lacey R. Pflibsen, et al.
Neurobiology of Disease (2011) Vol. 45, Iss. 3, pp. 1051-1067
Closed Access | Times Cited: 41
Delivery of CDNF by AAV-mediated gene transfer protects dopamine neurons and regulates ER stress and inflammation in an acute MPTP mouse model of Parkinson’s disease
Jin Han Nam, Christopher T. Richie, Brandon K. Harvey, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Comprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers
Joshua T. Dearborn, Steven K. Harmon, Stephen C. Fowler, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 33
Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson's disease
Dian-Shuai Gao, Chuanxi Tang, Jing Chen, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1107-1107
Open Access | Times Cited: 15
Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson’s disease
Cindy Moore, Mo Xu, Jerry K. Bohlen, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 7, pp. 2061-2077
Closed Access | Times Cited: 21
Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease
Madeline J. Churchill, Mark A. Cantu, Ella A. Kasanga, et al.
Neuroscience (2019) Vol. 414, pp. 8-27
Closed Access | Times Cited: 22
Targeted deletion of GD3 synthase protects against MPTP‐induced neurodegeneration
Yada Akkhawattanangkul, Panchanan Maiti, Yi Xue, et al.
Genes Brain & Behavior (2017) Vol. 16, Iss. 5, pp. 522-536
Open Access | Times Cited: 21
Executive function deficits and glutamatergic protein alterations in a progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease
Lacey R. Pflibsen, Katherine A. Stang, Michelle D. Sconce, et al.
Journal of Neuroscience Research (2015) Vol. 93, Iss. 12, pp. 1849-1864
Open Access | Times Cited: 18
Methyl aspartylphenylalanine, the pons and cerebellum in mice: An evaluation of motor, morphological, biochemical, immunohistochemical and apoptotic effects
Adejoke Y. Onaolapo, Olakunle J. Onaolapo, Polycarp U. Nwoha
Journal of Chemical Neuroanatomy (2017) Vol. 86, pp. 67-77
Closed Access | Times Cited: 18
Lack of Tryptophan Hydroxylase-1 in Mice Results in Gait Abnormalities
Georgette L. Suidan, Daniel Duerschmied, Gregory M. Dillon, et al.
PLoS ONE (2013) Vol. 8, Iss. 3, pp. e59032-e59032
Open Access | Times Cited: 17
miR-3099 promotes neurogenesis and inhibits astrogliogenesis during murine neural development
Shahidee Zainal Abidin, Sze-Zheng Fam, Chan‐Eng Chong, et al.
Gene (2019) Vol. 697, pp. 201-212
Open Access | Times Cited: 13
Intranasal exposure of manganese induces neuroinflammation and disrupts dopamine metabolism in the striatum and hippocampus
Irina S. Ivleva, Nina S. Pestereva, Alexander Zubov, et al.
Neuroscience Letters (2020) Vol. 738, pp. 135344-135344
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top